Corporate Development is a key pillar to our growth strategy.
As a leader in sleep medicine and with a growing hematology/oncology portfolio, we are developing meaningful medicines and bringing them to people with unaddressed needs around the world. We work to expand the science behind our medicines, acquire new therapies that will make a difference in patients’ lives, and partner to develop early-stage or later-stage molecules with great potential – reaffirming our commitment to patients with each decision. We seek solutions for rare or complex diseases, and we help ensure those solutions are available for the often-overlooked patients who need them.
One of the key components of our growth strategy is ongoing corporate development. Our team actively seeks opportunities to acquire or in-license development-stage (both preclinical and clinical), near-commercial and commercial products that are highly differentiated.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.